HomeWebinarsAdvanced Perfusion Processes: Design Criteria & Strategies

Advanced Perfusion Processes: Design Criteria & Strategies


Rising cost pressures in the biopharma industry and the demand for biopharmaceutical companies to diversify their biologics portfolio require them to manufacture in smaller and more flexible plants. New high-density cell culture processes, such as concentrated perfusion, present suitable solutions to adapt to these new manufacturing conditions and to facilitate a shift toward single-use technologies.

Perfusion processing relies on the constant addition of fresh medium and the removal of spent medium from an operating bioreactor. The next generation of perfusion processes might require an increased medium depth; this is partly because of low perfusion rates of 1-2 reactor volumes per day, which sometimes are even smaller than that.

In this webinar we will discuss:

  • The selection and optimization of scale-down models
  • Suitability of single-use bioreactors
  • Approaches for medium development
  • Balancing nutrients
  • Performance optimization using multi-variate approaches


Dr. Jochen B. Sieck


Head of Laboratory Cell Culture

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.